ApprovalTrail

Drug · DIN 02510782

EXCAUGH

Authorized, not yet reported as sold

Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.

Status Approved since January 8, 2021.
Drug Identification Number (DIN)
02510782
Company (DIN owner)
Fortune Pharmacal Co. Ltd.New Territories, Hong Kong, China
Schedule
Non-prescription drugs
Dosage form
Tablet
Route
Oral
Therapeutic class (ATC)
Guaifenesin R05CA03
Class
Human
Record last updated
May 29, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
GUAIFENESIN100 MG